Nolato AB (publ) (STO:NOLA.B)
Sweden · Delayed Price · Currency is SEK 48.95
+1.10 (2.30%)
At close: Jun 12, 2026
Nolato AB Market Cap
Nolato AB has a market cap or net worth of 13.19 billion as of June 12, 2026. Its market cap has decreased by -18.07% in one year.
Market Cap
13.19B
Enterprise Value
14.15B
Revenue
9.37B
Ranking
n/a
PE Ratio
17.42
Stock Price
48.95
Market Cap Chart
Since December 6, 1996, Nolato AB's market cap has increased from 660.32M to 13.19B, an increase of 1,896.93%. That is a compound annual growth rate of 10.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 13.19B | -20.79% |
| Dec 30, 2025 | 16.65B | 14.02% |
| Dec 30, 2024 | 14.60B | 2.46% |
| Dec 29, 2023 | 14.25B | -3.20% |
| Dec 30, 2022 | 14.72B | -49.35% |
| Dec 30, 2021 | 29.07B | 30.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 58.22B |
| Getinge AB | 51.36B |
| Elekta AB | 19.89B |
| Vitrolife AB | 13.03B |
| Xvivo Perfusion AB | 8.41B |
| MedCap AB | 7.47B |
| CellaVision AB | 3.13B |
| Devyser Diagnostics AB | 1.52B |